Ardelyx | ARDX - Stammkapital





Stammkapital Veränderung Datum
Abbott USD 1.74B 23.39B 2025-09
Amgen USD 539M 1000K 2025-12
Ardelyx USD 244.35M 1.38M 2025-12
aTyr Pharma USD 16.65M 81.34M 2025-12
Corcept Therapeutics USD 105.97M 842K 2025-12
Curis USD 59K 934K 2023-09
TG Therapeutics USD 155.21M 2.81M 2025-09
United Therapeutics USD 43.64M 740K 2025-12
Xoma USD 87K 1000 2024-06